Syneron Receives CE Mark for Stretch Mark and Acne Scar Treatment
Syneron Medical (NASDAQ: ELOS) announced today that its proprietary Sublative technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars. The new treatment protocols are now available on all of the Syneron Sublative compatible systems, which include elos Plus, eTwo and eMatrix
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.